Comparative effectiveness of sleeve gastrectomy versus Roux-en-Y gastric bypass for weight loss and safety outcomes in older adults
Autor: | Robert A. Casillas, Benjamin Kim, Jorge L. Zelada Getty, Heidi Fischer, Karen J. Coleman, Scott S. Um |
---|---|
Rok vydání: | 2016 |
Předmět: |
Male
medicine.medical_specialty Sleeve gastrectomy medicine.medical_treatment Gastric Bypass 030209 endocrinology & metabolism Patient Readmission 03 medical and health sciences 0302 clinical medicine Postoperative Complications Weight loss Gastrectomy Diabetes mellitus Weight Loss medicine Humans Propensity Score Aged business.industry Length of Stay medicine.disease Roux-en-Y anastomosis Obesity Surgery Obesity Morbid Treatment Outcome Propensity score matching 030211 gastroenterology & hepatology Female Laparoscopy Patient Safety medicine.symptom Complication business Body mass index |
Zdroj: | Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery. 13(9) |
ISSN: | 1878-7533 |
Popis: | Background Most bariatric studies in older adult patients have focused on older operations with limited follow-up and equivocal results. Objectives To compare weight loss and safety in patients ages≥65 years undergoing laparoscopic sleeve gastrectomy (SG) and laparoscopic Roux-en-Y gastric bypass (LRYGB). Setting Nine different bariatric surgery centers with 23 surgeons serving over 30,000 bariatric patients. Methods Participants were≥65 years who had a SG or LRYGB between January 1, 2010, and March 15, 2015. Outcomes measured were change in weight up to 4 years after surgery; 30-, 90-, and 365-day mortality; and early (≤30 d) and late (31–365 d) complication rates. To control for nonrandom assignment, SG and LRYGB cases were propensity matched at the time of surgery for gender, race/ethnicity, procedure year, body mass index, presence of diabetes and/or hypertension, and overall co-morbidity burden. Results There were 177 LRYGB and 252 SG patients (n = 429). Patients were female (70%), 67 years old (range 65 to 79), non-Hispanic white (64%), and had a body mass index of 42.6±5.4 kg/m2. The year 4 follow-up rate was 75% (n = 322). LRYGB patients lost significantly more weight than SG after a median 4 years of follow-up (P Conclusions Elderly patients lost significantly more weight with LRYGB compared with SG. Further studies will be necessary to determine if the long-term effects of greater weight loss warrant the increased risk involved with LRYGB. |
Databáze: | OpenAIRE |
Externí odkaz: |